Investigation of Intravenous Hydroxocobalamin Compared to Hextend for Resuscitation in a Swine Model of Uncontrolled Hemorrhagic Shock: A Preliminary Report
Abstract
Previously we reported that intravenous (IV) hydroxocobalamin is as effective as IV Hextend in improving systolic blood pressure (SBP) in a controlled hemorrhagic shock model. We aimed to compare IV hydroxocobalamin (HOC) to Hextend using an uncontrolled hemorrhage model. Non-compressible wounds are difficult to treat. An ideal resuscitative fluid would be a small volume, portable drug that improves blood pressure and survival.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 27, 2017
- Accession Number
- AD1040799
Entities
People
- D. Hyams
- Joseph K Maddry
- K. Canellis
- M. Castaneda
- N. Garrett
- S. Boudreau
- V. S. Bebarta
Organizations
- 59th Medical Wing